Tercica, Inc. To Release Third Quarter Financial Results On November 2

BRISBANE, Calif., Oct. 19 /PRNewswire-FirstCall/ -- Tercica, Inc. announced today that it will release its third quarter financial results on November 2, 2005 at 4:00 p.m. EST. The Company will also host a live conference call and webcast at 4:30 p.m. EST that same day.

To access the live teleconference, dial 888-803-8296 (U.S.) or 706-634-1250 (international) and reference conference ID# 1672385. To access the webcast, please log on to the Company's website at www.tercica.com.

A replay of the webcast and teleconference will be available approximately three hours after the call for seven business days. To access the replay, please call 800-642-1687 (U.S.) or 706-645-9291 (international).

About Tercica

Tercica, Inc. is a biopharmaceutical company focused on the development and commercialization of products to improve endocrine health. The company's first product, Increlex(TM) or recombinant human insulin-like growth factor-1 (rhIGF-1) was approved for the long-term treatment of severe Primary IGFD. For further information on Tercica, please visit www.tercica.com.

CONTACT: investors, Ina McGuinness Vice President, CorporateCommunications & Investor Relations, +1-650-624-4949, orina.mcguinness@tercica.com, or media, Kathleen Rinehart, Public RelationsDirector, +1-650-624-4948, or kathleen.rinehart@tercica.com, both ofTercica

Web site: http://www.tercica.com/